GlobeNewsWire
23 Jun 2026, 00:16 UTC · 2h ago
COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
23 Jun 2026, 00:16 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
COSCIENS Biopharma plans to file a Form 15 with the SEC to suspend its reporting obligations in the United States. — Delisting from US reporting obligations typically reduces liquidity and transparency, making the stock less attractive to US institutional investors.
-0.60The company will implement a 150-to-1 reverse stock split followed by a 1-to-50 forward split effective July 3, 2026. — While nominally a capital restructure, aggressive reverse splits are often viewed by the market as a defensive move to maintain listing requirements.
-0.20Shareholders holding fewer than 150 common shares will be cashed out at US$1.60 per pre-Consolidation share. — This is a mechanical execution of the share capital amendment and does not fundamentally change the company's valuation.
+0.00Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is announcing technical changes to its share capital and reporting obligations, which are generally neutral administrative actions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
1h ago
